國立高雄大學圖資館 |

Language: English

Back

Practical guide to hereditary breast and ovarian cancerannual meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021 /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Practical guide to hereditary breast and ovarian canceredited by Daisuke Aoki, Seigo Nakamura, Yoshio Miki.
Reminder of title:	annual meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021 /
other author:	Aoki, Daisuke.
Corporate Body:	Japanese Organization of Hereditary Breast and Ovarian Cancer.
Published:	Singapore :Springer Nature Singapore :2023.
Description:	vi, 154 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	BreastCongresses.Cancer
Online resource:	https://doi.org/10.1007/978-981-99-5231-1
ISBN:	9789819952311$q(electronic bk.)

Practical guide to hereditary breast and ovarian cancerannual meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021 /
Japanese Organization of Hereditary Breast and Ovarian Cancer.Annual Meeting(2021)

Practical guide to hereditary breast and ovarian cancerannual meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021 /[electronic resource] :edited by Daisuke Aoki, Seigo Nakamura, Yoshio Miki. - Singapore :Springer Nature Singapore :2023. - vi, 154 p. :ill., digital ;24 cm.

Part I Breast -- 1 Establishment of a medical system with HBOC in mind -- 2 Guidelines for diagnosis and treatment of HBOC: Methods and Products -- 3 RRM from a Plastic Surgery Perspective -- Part 2 Gynecology -- 4 Significance of p53 signature in RRSO samples -- 5 Mutual feedback between gynecological HBOC practice and cancer genomic medicine -- Part 3 Basic Science -- 6 Diversity of HBOC-Related Genes Revealed by Genome Analysis -- 7 New functions of BRCA1/2 regulating carcinogenesis and drug sensitivity -- Part 4 Health and Labor Sciences Research Grant -- 8 Systemic Issues in HBOC Treatment -- 9 Current status and future issues of the activities of the relevant organizations -- Part 5 Congress Award -- 10 Understanding the significance of the test in relatives of prostate and pancreatic cancer patients who tested positive on BRACAnalysis -- 11 Handling Germline Findings in Ovarian Cancer Cases -- Part 6 JOHBOC registration -- 12 JOHBOC registration data up to date 2021.

This book shares cutting-edge evidence on Hereditary Breast and Ovarian Cancer (HBOC) treatment, delivering facts on breast cancer, gynecologic oncology, and basic research to contribute to clinicians' practices. Each chapter presents the latest clinical techniques, basic experimental results, and the best-chosen research findings. The book is based on the works presented at the Japanese Organization of Hereditary Brest and Ovarian Cancer (JOHBOC) and a special chapter delivers a study based on the extensive data from the Japanese HBOC patients registered in the society's database, presenting novel evidence for further advancement in the field. The practice for HBOC has been rapidly increasing due to the clinical development of poly(ADP-ribose) polymerase inhibitors and the spread of companion diagnostics. In addition, the insurance coverage of a part of HBOC treatment raised social awareness in Japan, and the book illustrates not only clinical efforts but also issues related to the social system and the efforts of the association of related organizations. Hereditary Breast and Ovarian Cancer - Annual meeting of JOHBOC will be of interest to breast surgeons, obstetricians and gynecologists, pancreatic cancer surgeons, and urologists engaged in HBOC treatment through the implementation of companion diagnostics for PARP inhibitors administration. Also, physicians occupied in genetic medicine who perform genetic testing and medical staff practicing HBOC will find this book insightful. It is also for HBOC patients and their families, medical administrators in the social system of HBOC practice. Editors and authors hope to contribute to the equalization and widespread of HBOC practice and serve as a foundation for future advances in the disease's treatment and medical practice.

ISBN: 9789819952311$q(electronic bk.)

Standard No.: 10.1007/978-981-99-5231-1doiSubjects--Topical Terms:

962845
Breast
--Cancer--Congresses.

LC Class. No.: RC280.B8 / J373 2021

Dewey Class. No.: 616.99449

Practical guide to hereditary breast and ovarian cancerannual meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021 /
LDR:03892nmm a2200325 a 4500 001 652348
003 DE-He213
005 20231031141129.0
006 m d
007 cr nn 008maaau
008 240327s2023 si s 0 eng d
020 $a 9789819952311$q(electronic bk.)
020 $a 9789819952304$q(paper)
024 7 $a 10.1007/978-981-99-5231-1 $2 doi
035 $a 978-981-99-5231-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8 $b J373 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449 $2 23
090 $a RC280.B8 $b J35 2021
110 2 $a Japanese Organization of Hereditary Breast and Ovarian Cancer. $b Annual Meeting $d (2021) $3 962844
245 1 0 $a Practical guide to hereditary breast and ovarian cancer $h [electronic resource] : $b annual meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2021 / $c edited by Daisuke Aoki, Seigo Nakamura, Yoshio Miki.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a vi, 154 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part I Breast -- 1 Establishment of a medical system with HBOC in mind -- 2 Guidelines for diagnosis and treatment of HBOC: Methods and Products -- 3 RRM from a Plastic Surgery Perspective -- Part 2 Gynecology -- 4 Significance of p53 signature in RRSO samples -- 5 Mutual feedback between gynecological HBOC practice and cancer genomic medicine -- Part 3 Basic Science -- 6 Diversity of HBOC-Related Genes Revealed by Genome Analysis -- 7 New functions of BRCA1/2 regulating carcinogenesis and drug sensitivity -- Part 4 Health and Labor Sciences Research Grant -- 8 Systemic Issues in HBOC Treatment -- 9 Current status and future issues of the activities of the relevant organizations -- Part 5 Congress Award -- 10 Understanding the significance of the test in relatives of prostate and pancreatic cancer patients who tested positive on BRACAnalysis -- 11 Handling Germline Findings in Ovarian Cancer Cases -- Part 6 JOHBOC registration -- 12 JOHBOC registration data up to date 2021.
520 $a This book shares cutting-edge evidence on Hereditary Breast and Ovarian Cancer (HBOC) treatment, delivering facts on breast cancer, gynecologic oncology, and basic research to contribute to clinicians' practices. Each chapter presents the latest clinical techniques, basic experimental results, and the best-chosen research findings. The book is based on the works presented at the Japanese Organization of Hereditary Brest and Ovarian Cancer (JOHBOC) and a special chapter delivers a study based on the extensive data from the Japanese HBOC patients registered in the society's database, presenting novel evidence for further advancement in the field. The practice for HBOC has been rapidly increasing due to the clinical development of poly(ADP-ribose) polymerase inhibitors and the spread of companion diagnostics. In addition, the insurance coverage of a part of HBOC treatment raised social awareness in Japan, and the book illustrates not only clinical efforts but also issues related to the social system and the efforts of the association of related organizations. Hereditary Breast and Ovarian Cancer - Annual meeting of JOHBOC will be of interest to breast surgeons, obstetricians and gynecologists, pancreatic cancer surgeons, and urologists engaged in HBOC treatment through the implementation of companion diagnostics for PARP inhibitors administration. Also, physicians occupied in genetic medicine who perform genetic testing and medical staff practicing HBOC will find this book insightful. It is also for HBOC patients and their families, medical administrators in the social system of HBOC practice. Editors and authors hope to contribute to the equalization and widespread of HBOC practice and serve as a foundation for future advances in the disease's treatment and medical practice.
650 0 $a Breast $x Cancer $x Genetic aspects $v Congresses. $3 962845
650 0 $a Ovaries $x Cancer $x Genetic aspects $v Congresses. $3 962846
650 1 4 $a Oncology. $3 195181
650 2 4 $a Minimally Invasive Surgery. $3 275872
650 2 4 $a Surgery. $3 274153
650 2 4 $a Cancer Genetics and Genomics. $3 918740
650 2 4 $a Biomedical Research. $3 243625
700 1 $a Aoki, Daisuke. $3 908983
700 1 $a Nakamura, Seigo. $3 908982
700 1 $a Miki, Yoshio. $3 908984
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-5231-1
950 $a Medicine (SpringerNature-11650)